Loading...
| A03447 | Pages: NA | Dec 2021 | 4515 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Professional Diagnostics Market
Request Now !Professional diagnostics are referred to those diagnostic methods that provide faster detection of diseases such as cancer, malaria, infections, blood glucose levels and others in an individual. The sole objective of the professional tests is to provide early diagnosis and hence an early treatment and have successfully replaced many laboratory and clinical experiments. The key factors that drive the market growth are increasing focus towards early diagnosis of chronic diseases such as cancer, malaria, among many others. In addition, rising need of early diagnosis of sepsis and acute cardiac infarction, boosts the demand for point of care tests (POCT) further fuelling the market growth. However, industry consolidation posing threat to new entrants along with dearth of skilled professionals restraints the market growth. Moreover, increasing technological developments in the field of professional diagnostics will offer lucrative opportunities for the market growth.
The report segments the market on the basis of product type, end users and region. Based on product type, the market is segmented into immunochemistry, clinical microbiology, point of care test (POCT), haematology, and haemostasis. Based on end users, the market is segmented into hospitals, diagnostic laboratories and others. Regionally, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players of the market are F. Hoffman-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Thermo Fischer Scientific Inc., Siemens Medical Solutions USA, Inc., Abaxis, Hologenic Inc., Bio-Rad Laboratories Inc., Becton, Dickenson and Company (BD), Alere and Enzo Biochem Inc.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4.PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
356.3. Opportunities
CHAPTER 4 GLOBAL PROFESSIONAL DIAGNOSTICS MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. IMMUNOCHEMISTRY
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. CLINICAL MICROBIOLOGY
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.5. POINT OF CARE TEST (POC)
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. HEMATOLOGY
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.6. HEMOSTASIS
4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
CHAPTER 5 GLOBAL PROFESSIONAL DIAGNOSTICS MARKET, BY END USERS
5.1. OVERVIEW
4.1.1. Market size and forecast
5.2. HOSPITALS
5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast
5.3. DIAGNOSTIC LABORATORIES
5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market Size And Forecast
5.4. OTHERS
5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market Size And Forecast
CHAPTER 6 GLOBAL PROFESSIONAL DIAGNOSTICS MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America Professional Diagnostics Market by Type
6.2.5. North America Professional Diagnostics Market by End Users
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast
6.3.5. Europe Professional Diagnostics Market by Types
6.3.4. Europe Professional Diagnostics Market by End Users
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.2.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific Professional Diagnostics Market by Types
6.4.5. Asia-Pacific Professional Diagnostics Market by End Users
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Argentina market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast
6.5.4. LAMEA Professional Diagnostics Market by Types
6.5.5. LAMEA Professional Diagnostics Market by End Users
CHAPTER 7 COMPANY PROFILES
7.1. ABBOTT LABORATORIES
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. SIEMENS MEDICAL SOLUTIONS USA, INC.
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.3. F. HOFFMANN LA ROCHE LTD
7.3.1. Operating Business Segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. THERMOFISCHER SCIENTIFIC INC.
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. ABAXIS
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.7. HOLOGIC INC.
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. BIO-RAD LABORATORIES INC
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. ALERE
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. ENZO BIOCHEM INC.
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. BECTON, DICKENSON AND COMPANY (BD)
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
